Registration statement for securities of certain foreign private issuers

Investments in Subsidiaries and Associates

v3.21.2
Investments in Subsidiaries and Associates
6 Months Ended 12 Months Ended
Jun. 30, 2021
Dec. 31, 2020
Text block [abstract]    
Investments in Subsidiaries and Associates
8.
Investments in subsidiaries and associates
The Group and Company have the following investments:
 
Subsidiary undertakings
 
Country of
Incorporation
    
Principal Activity
    
Ownership
(As at
June 30,
2021)
 
Company:
                         
Babylon Partners Limited     London, UK        Application development  
 
     100.0
Babylon Healthcare Services Limited     London, UK        Digital Healthcare services  
 
     100.0
Babylon Rwanda Limited     Kigali, Rwanda        Digital Healthcare services  
 
     100.0
Babylon Inc.     Delaware, USA        Digital Healthcare services  
 
     100.0
Babylon Malaysia SDN BDN     Kuala Lumpur, Malaysia  
 
     Digital Healthcare services  
 
     100.0
Babylon International Limited     London, UK        Digital Healthcare services  
 
     100.0
Babylon Health Ireland Limited     Cork, Ireland        Digital Healthcare services  
 
     100.0
Babylon Singapore PTE Limited     Singapore        Digital Healthcare services  
 
     100.0
Health Innovators Inc     Delaware, USA        Digital Healthcare services  
 
     78.0
Babylon Acquisition Corp     Delaware, USA        Digital Healthcare services  
 
     100.0
Babylon Technology LTDA     Brazil        Digital Healthcare services  
 
     100.0
Group:
                   
Babylon Healthcare Inc     Delaware, USA        Digital Healthcare services  
 
     100.0
Babylon Healthcare NJ, PC     New Jersey, USA  
 
     Healthcare services        100.0
Babylon Healthcare, PLLC     Maine, USA        Healthcare services        100.0
Babylon Medical Group (formerly Marcus Zachary DO), PC     California, USA        Healthcare services        100.0
California Telemedicine Associates, PC     California, USA        Healthcare services        100.0
Telemedicine Associates, PC     Maine, USA        Healthcare services        100.0
Babylon Healthcare, PC     Illinois, USA        Healthcare services        100.0
Babylon Healthcare NC, PC     North Carolina, USA  
 
     Healthcare services        100.0
Babylon Healthcare, PA     Pennsylvania, USA  
 
     Healthcare services        100.0
Meritage Medical Network     California, USA        Healthcare services        100.0
Meritage Health Ventures, LLC     California, USA        Healthcare services        100.0
Subsidiary undertakings
 
Country of
Incorporation
    
Principal Activity
    
Ownership
(As at
June 30,
2021)
 
Group:
                   
Meritage Health Plan     California, USA        Healthcare services        100.0
Meritage Management, LLC     California, USA        Healthcare services        100.0
Meritage ACO, LLC     California, USA        Healthcare services        100.0
First Choice 360 Care Solutions     California, USA        Healthcare services        100.0
       
Investment in Associates:
                         
       
Higi SH Holdings Inc.     Delaware, USA        Digital Healthcare services  
 
     25.0
Health Innovators
Babylon acquired equity interests in Health Innovators Inc. in 2019. In the event of a liquidation, Babylon has a preferential right to recover amounts invested prior to other shareholders or receive its percentage of net assets of Health Innovators, whichever is greater. Since the acquisition date the net assets of Health Innovators Inc. have been less than Babylon’s total investment, therefore Babylon consolidates 100.0% of Health Innovators Inc.’s net assets and no NCI is recognized.
Higi
On May 15, 2020 Babylon Acquisition Corp. acquired 11.0% of the preference shares in Higi SH Holdings Inc. (“Higi”). Higi provides digital healthcare services via a network of Smart Health Stations located around the USA, the investment is in line with the Group’s objective to provide accessible and affordable healthcare.
The Group had the option to increase their shareholding in Higi to 25% exercisable over the period to June 2021 and subsequently has the option to purchase the remaining 75% of shares exercisable over the period to May 2023. At June 30, 2021 the total shareholding was 25.0%.
Higi is accounted for as an associate because the Group is able to demonstrate significant influence over Higi through representation on the board, the power to participate in policy. During the period to June 30, 2021 the Group did not have the substantive rights to exert control over Higi due to the existence of significant barriers that prevented exercise of the purchase option.
The following table summarizes the financial information of Higi as of June 30, 2021:
 
    
$’000
 
Non-current
assets
     684  
Current Assets
     8,250  
Non-current
liabilities
     (7,000
Current liabilities
     (3,244
    
 
 
 
Net assets (100%)
    
(1,310
)
 
Revenue
     4,621  
    
 
 
 
Total comprehensive loss
    
(5,621
)
 
    
 
 
 
 
As of June 30, 2021, our financial statements includes a total carrying amount of $12,600 thousand, total investment of $15,000 thousand and a loss of $1,276 thousand related to Higi. If the Group did have substantive rights to exert control over Higi, management estimates that consolidated losses would have been $80,135 thousand (higher by $4,346 thousand) and consolidated net assets would have been $56,710 thousand (lower by $1,090 thousand) for the six months ended June 30, 2021.
Professional service corporations
As discussed in Note 2, we consolidated certain professional service corporations (“PCs”) which are owned, directly or indirectly, and operated by licenses physicians. The following provides summary financial data for the PCs that are included in the Interim Financial Statements:
 
    
June 30,
2021
    
December 31,
2020
 
    
$’000
    
$’000
 
Total assets
     66,489        35,535  
Total liabilities
     81,429        42,699  
 
    
Six Months Ended June 30,
 
    
2021
    
2020
 
    
$’000
    
$’000
 
Total revenues
     35,786        1,036  
Operating expenses:
                 
Cost of care delivery
     (36,710      (942
Sales, general and administrative expenses
     (4,404      (119
    
 
 
    
 
 
 
Total operating expenses
  
 
(41,114
  
 
(1,061
    
 
 
    
 
 
 
16.
Investments in subsidiaries and associates
The Group and Company have the following investments:
 
Subsidiary undertakings
 
Country of Incorporation
   
Principal Activity
   
Ownership
(As at
December 31,
2020)
   
Ownership
(As at
December 31,
2019)
 
Company:
                               
Babylon Partners Limited     London, UK       Application development       100.0     100.0
Babylon Healthcare Services Limited     London, UK       Digital Healthcare services       100.0     100.0
Babylon Rwanda Limited     Kigali, Rwanda       Digital Healthcare services       100.0     100.0
Babylon Inc.     Delaware, USA       Digital Healthcare services       100.0     100.0
Babylon Health Canada Limited     British Columbia, Canada       Digital Healthcare services       100.0     100.0
Babylon Malaysia SDN BDN     Kuala Lumpur, Malaysia       Digital Healthcare services       100.0     100.0
Babylon International Limited     London, UK       Digital Healthcare services       100.0     100.0
Babylon Health Ireland Limited     Cork, Ireland       Digital Healthcare services       100.0     100.0
Babylon Singapore PTE Limited     Singapore       Digital Healthcare services       100.0     100.0
Health Innovators Inc     Delaware, USA       Digital Healthcare services       70.1     58.0
Babylon Acquisition Corp     Delaware, USA       Digital Healthcare services       100.0     —    
Babylon Technology LTDA     Brazil       Digital Healthcare services       100.0     —    
Group:
                               
Babylon Healthcare Inc     Delaware, USA       Digital Healthcare services       100.0     —    
Babylon Healthcare NJ, PC*     New Jersey, USA       Healthcare services       100.0     —    
Babylon Healthcare, PLLC*     Maine, USA       Healthcare services       100.0     —    
Marcus Zachary DO, OC*     California, USA       Healthcare services       100.0     —    
California Telemedicine Associates, PC*     California, USA       Healthcare services       100.0     —    
Telemedicine Associates, PC*     Maine, USA       Healthcare services       100.0     —    
Babylon Healthcare, PC*     Illinois, USA       Healthcare services       100.0     —    
Babylon Healthcare NC, PC*     North Carolina, USA       Healthcare services       100.0     —    
         
Investment in Associates:
                               
Higi SH Holdings Inc.  
 
Delaware, USA
 
 
 
Digital Healthcare services
 
    19.0     —    
 
*
Subsidiary is a PC, which is included in the Consolidated Financial Statements of the Group on the basis of control. Refer to Note 2 for additional discussion.
Health Innovators, Inc.
Babylon acquired Health Innovators Inc. in 2019. In the event of a liquidation, Babylon has a preferential right to recover amounts invested prior to other shareholders or receive its percentage of net assets of Health Innovators, whichever is greater. Since the acquisition date the net assets of Health Innovators Inc. have been less than Babylon’s total investment, therefore Babylon consolidates 100.0% of Health Innovators Inc.’s net assets and no NCI is recognized. Refer to Note 5 for additional information.
Higi
On May 15, 2020 Babylon Acquisition Corp. acquired 11.0% of the preference shares in Higi SH Holdings Inc. (“Higi”). Higi provides digital healthcare services via a network of Smart Health Stations located around the USA, the investment is in line with the Group’s objective to provide accessible and affordable healthcare.
The Group has the option to increase their shareholding in Higi to 25% exercisable over the period to July 2021 and subsequently the option to purchase the remaining 75% of shares exercisable over the period to May 2023. At December 31, 2020 the total shareholding was 19.0%.
Higi is accounted for as an associate because the Group is able to demonstrate significant influence over Higi through representation on the board, the power to participate in policy. During the period to December 30, 2020 the Group did not have the substantive rights to exert control over Higi due to the existence of significant barriers that prevented exercise of the purchase option.
The following table summarizes the financial information of Higi as of December 31, 2020:
 
    
$’000
 
Non-current
assets
     1,792  
Current Assets
     10,403  
Non-current
liabilities
     8,670  
Current liabilities
     4,661  
    
 
 
 
Net assets (100%)
  
 
(1,136
Revenue
     9,486  
    
 
 
 
Total comprehensive loss
  
 
(13,558
As of December 31, 2020, our financial statements includes a total carrying amount of $8,876 thousand, total investment of $10,000 thousand and a loss of $1,124 thousand related to Higi. If the Group did have substantive rights to exert control over Higi, management estimates that consolidated losses would have been $190,378 thousand (higher by $7,041 thousand) and consolidated net assets would have been $53,875 thousand (higher by $541 thousand) for the year ended December 31, 2020.